Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation

NCT03843528 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Myelodysplastic Syndromes
Mixed Phenotype Acute Leukemia
Juvenile Myelomonocytic Leukemia

Interventions

DRUG: Vorinostat
DRUG: Azacitidine Injection

Sponsor

Johns Hopkins All Children's Hospital